Central nervous system involvement in cryptococcal infection in individuals after solid organ transplantation or with AIDS

Transplant Infectious Disease

Volumn 11, Issue 5, 2009, Pages 432-437

  Davis, J A ^a   Horn, D L ^b   Marr, K A ^c   Fishman, J A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AIDS; Central nervous system; Cryptococcal infection; Cryptococcus neoformans; Solid organ transplantation

Indexed keywords

CALCINEURIN INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CENTRAL NERVOUS SYSTEM INFECTION; COHORT ANALYSIS; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; FEMALE; GRAFT RECIPIENT; HEART TRANSPLANTATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MENINGITIS; MORTALITY; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; UNIVARIATE ANALYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CENTRAL NERVOUS SYSTEM FUNGAL INFECTIONS; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; FEMALE; HIV INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MENINGITIS, CRYPTOCOCCAL; MIDDLE AGED; ORGAN TRANSPLANTATION; PROGNOSIS; YOUNG ADULT;

EID: 70349655383     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2009.00424.x     Document Type: Article

References (21)

1. Fishman JA. Infection in solid-organ transplant recipients. N Engl J Med 2007 357 (25) : 2601 2614.
2. Pukkila-Worley R, Mylonakis E. Epidemiology and management of cryptococcal meningitis: developments and challenges. Expert Opin Pharmacother 2008 9 (4) : 551 560.
3. Vilchez RA, Irish W, Lacomis J, Costello P, Fung J, Kusne S. The clinical epidemiology of pulmonary cryptococcal infection in non-AIDS patients at a tertiary care medical center. Medicine (Baltimore) 2001 80 (5) : 308 312.
4. Husain S, Wagener MM, Singh N. Cryptococcus neoformans infection in organ transplant recipients: variables influencing clinical characteristics and outcome. Emerg Infect Dis 2001 7 (3) : 375 381.
5. Wu G, Vilchez RA, Eidelman B, Fung J, Kormos R, Kusne S. Cryptococcal meningitis: an analysis among 5,521 consecutive organ transplant recipients. Transpl Infect Dis 2002 4 (4) : 183 188.
6. Mirza SA, Phelan M, Rimland D, et al. The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992-2000. Clin Infect Dis 2003 36 (6) : 789 794.
7. Lortholary O, Poizat G, Zeller V, et al. Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy. AIDS 2006 20 (17) : 2183 2191.
8. Singh N, Alexander BD, Lortholary O, et al. Cryptococcus neoformans in organ transplant recipients: impact of calcineurin-inhibitor agents on mortality. J Infect Dis 2007 195 (5) : 756 764.
9. Fishman JA, Gonzalez RG, Branda JA. Case records of the Massachusetts General Hospital: case 11-2008 - a 45-year-old man with changes in mental status after liver transplantation. N Engl J Med 2008 358 : 1604 1613.
10. Pinner RW, Hajjeh RA, Powderly WG. Prospects for preventing cryptococcosis in persons infected with human immunodeficiency virus. Clin Infect Dis 1995 21 (Suppl 1) : S103 S107.
11. Hajjeh RA, Conn LA, Stephens DS, et al. Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. Cryptococcal Active Surveillance Group. J Infect Dis 1999 179 (2) : 449 454.
12. Horn DL, Fishman JA, Steinbach WJ, et al. Presentation of the PATH Alliance registry for prospective data collection and analysis of the epidemiology, therapy, and outcomes of invasive fungal infections. Diagn Microbiol Infect Dis 2007 59 (4) : 407 414.
13. Singh N, Lortholary O, Alexander BD, et al. Antifungal management practices and evolution of infection in organ transplant recipients with Cryptococcus neoformans infection. Transplantation 2005 80 (8) : 1033 1039. (Pubitemid 41611924)
14. Jongwutiwes U, Sungkanuparph S, Kiertiburanakul S. Comparison of clinical features and survival between cryptococcosis in human immunodeficiency virus (HIV)-positive and HIV-negative patients. Jpn J Infect Dis 2008 61 : 111 115.
15. Odom A, Del Poeta M, Perfect J, Heitman J. The immunosuppressant FK506 and its nonimmunosuppressive analog L-685,818 are toxic to Cryptococcus neoformans by inhibition of a common target protein. Antimicrob Agents Chemother 1997 41 (1) : 156 161.
16. Odom A, Muir S, Lim E, Toffaletti DL, Perfect J, Heitman J. Calcineurin is required for virulence of Cryptococcus neoformans. EMBO J 1997 16 (10) : 2576 2589.
17. Fox DS, Cruz MC, Sia RA, et al. Calcineurin regulatory subunit is essential for virulence and mediates interactions with FKBP12-FK506 in Cryptococcus neoformans. Mol Microbiol 2001 39 (4) : 835 849.
18. Blankenship JR, Singh N, Alexander BD, Heitman J. Cryptococcus neoformans isolates from transplant recipients are not selected for resistance to calcineurin inhibitors by current immunosuppressive regimens. J Clin Microbiol 2005 43 (1) : 464 467.
19. Kontoyiannis DP, Lewis RE, Alexander BD, et al. Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: correlation with outcome in solid organ transplant recipients with cryptococcosis. Antimicrob Agents Chemother 2008 52 (2) : 735 738.
20. Brouwer AE, Siddiqui AA, Kester MI, et al. Immune dysfunction in HIV-seronegative, Cryptococcus gattii meningitis. J Infect 2007 54 (3) : e165 e168.
21. Beenhouwer DO, Yoo EM, Lai CW, Rocha MA, Morrison SL. Human immunoglobulin G2 (IgG2) and IgG4, but not IgG1 or IgG3, protect mice against Cryptococcus neoformans infection. Infect Immun 2007 75 (3) : 1424 1435.